Jones Clinic

Germantown, Tennessee 38138

0 studies enrolling now · 6 studies all time

What they study most

Breast Adenocarcinoma, Clear Cell Renal Cell Carcinoma, Colon Adenocarcinoma, Estrogen Receptor Positive Breast Cancer, Hormone Receptor Positive, Kidney Cancer, Progesterone Receptor Positive Tumor, Recurrent Breast Carcinoma, Stage I Renal Cell Cancer AJCC v6 and v7, Stage IA Breast Cancer, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer

Studies at this site

• Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) — Running, not enrolling
• Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery — Completed
• Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery — Completed
• Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer — Running, not enrolling
• Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer — Completed
• Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer) — Completed